Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

7 months ago 20
Read Entire Article
  1. Homepage
  2. Finance
  3. Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

Related

Manufacturing PMI data takes center stage Friday

Manufacturing PMI data takes center stage Friday

1 hour ago 0
Russia asks US to stop pursuit of fleeing oil tanker, NY Times reports

Russia asks US to stop pursuit of fleeing oil tanker, NY Tim...

2 hours ago 2
World reacts to fatal fire at Swiss ski resort bar

World reacts to fatal fire at Swiss ski resort bar

2 hours ago 2

Trending

1. texas flooding
2. ty simpson
3. jam miller
4. omar cooper jr
5. fernando mendoza brother
6. josh cuevas
7. mikail kamara
8. michael lippman
9. indiana football coach
10. germie bernard

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 652
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 516
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

10 months ago 383
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

10 months ago 339
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

1 year ago 333
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2026. All rights are reserved